Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Eledon Pharmaceuticals (ELDN)

Eledon Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELDN
DateTimeSourceHeadlineSymbolCompany
04/03/202521:05GlobeNewswire Inc.Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare ConferenceNASDAQ:ELDNEledon Pharmaceuticals Inc
14/02/202522:34Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELDNEledon Pharmaceuticals Inc
14/02/202516:22Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELDNEledon Pharmaceuticals Inc
07/02/202515:00GlobeNewswire Inc.Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a HumanNASDAQ:ELDNEledon Pharmaceuticals Inc
29/01/202521:05GlobeNewswire Inc.Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech ConferenceNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202522:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202522:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202522:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202522:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202522:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202522:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202522:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202522:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202522:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202512:00GlobeNewswire Inc.Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 OutlookNASDAQ:ELDNEledon Pharmaceuticals Inc
20/12/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELDNEledon Pharmaceuticals Inc
22/11/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
22/11/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
14/11/202421:51Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELDNEledon Pharmaceuticals Inc
12/11/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELDNEledon Pharmaceuticals Inc
12/11/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELDNEledon Pharmaceuticals Inc
12/11/202421:01GlobeNewswire Inc.Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial ResultsNASDAQ:ELDNEledon Pharmaceuticals Inc
06/11/202421:05GlobeNewswire Inc.Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation ConferenceNASDAQ:ELDNEledon Pharmaceuticals Inc
05/11/202416:44Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ELDNEledon Pharmaceuticals Inc
30/10/202410:36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELDNEledon Pharmaceuticals Inc
30/10/202410:24Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELDNEledon Pharmaceuticals Inc
30/10/202401:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELDNEledon Pharmaceuticals Inc
29/10/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELDNEledon Pharmaceuticals Inc
29/10/202411:46GlobeNewswire Inc.Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsNASDAQ:ELDNEledon Pharmaceuticals Inc
29/10/202411:45GlobeNewswire Inc.Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago MedicineNASDAQ:ELDNEledon Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ELDN